← Back to headlines
VERAXA Biotech Secures $27.5M Financing and Plans SPAC Merger
VERAXA Biotech has announced it secured $27.5 million in financing and intends to go public through a SPAC merger.
28 May, 16:53 — 28 May, 16:53
Sources
Showing 1 of 1 sources
Related Stories
Climate Catastrophes in Europe Cost Billions, Burdening Citizens
20m ago
Former Google CEO Eric Schmidt Selling Superyacht for €149 Million
21m ago
Berkshire Hathaway's Significant Investment in Alphabet Stock
28m ago
Fabrinet Shares Decline Despite Earnings Beat Due to Margin and Cash Flow Concerns
44m ago